ADVFN Logo ADVFN
시장 데이터
뉴스
도구
시장
팔로우

Hot Features

피드 팔로우

Follow Feed 커뮤니티에서 거래자 및 투자자와 연결하세요.

실시간 옵션 플로우

포괄적인 옵션 데이터를 탐색하고 옵션 흐름으로 고급 필터를 사용하세요.

모니터

터미널 모니터로 주식 및 자산 관심 목록을 구성하고 모니터링하세요.
로그인 Premium Icon프리미엄 Help Menu
S&P 500
5,304.72
0.70%
US Tech 100
18,318.00
0.95%
다우존스 지수
39,069.59
0.01%
Bitcoin
69,182.00
0.95%
Registration Strip Icon for charts 실시간 차트, 분석 도구 및 가격을 받으려면 등록하세요.
등록
  1. 홈
  2. 인베스팅
  3. 주식
  4. 미국
  5. NASDAQ
  6. Twist Bioscience Corporation (TWST)

  7. Twist Bioscience Corporation (TWST) 뉴스

TWST

Twist Bioscience (TWST)

Twist Bioscience Corporation
일자:
정렬 기준:
 검색 관련기사 보기:NASDAQ:TWST
일자시간출처헤드라인심볼기업
2024/05/2404:20Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:TWSTTwist Bioscience Corporation
2024/05/2321:00Business WireTwist Bioscience to Present at Upcoming Investor ConferencesNASDAQ:TWSTTwist Bioscience Corporation
2024/05/1321:00Business WireTwist Bioscience Launches Multiplexed Gene Fragments to Enable High-throughput Screening ApplicationsNASDAQ:TWSTTwist Bioscience Corporation
2024/05/0821:00Business WireTwist Bioscience Corporation Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)NASDAQ:TWSTTwist Bioscience Corporation
2024/05/0805:05Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:TWSTTwist Bioscience Corporation
2024/05/0805:05Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:TWSTTwist Bioscience Corporation
2024/05/0805:05Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:TWSTTwist Bioscience Corporation
2024/05/0305:05Business WireTwist Bioscience Reports Fiscal Second Quarter 2024 Financial ResultsNASDAQ:TWSTTwist Bioscience Corporation
2024/04/1821:00Business WireTwist Bioscience to Report Fiscal 2024 Second Quarter Financial Results on Thursday, May 2, 2024NASDAQ:TWSTTwist Bioscience Corporation
2024/03/2821:00Business WireTwist Bioscience Launches Pangenome Spike-in Exome Panel to Enable Advancement of Research for Diverse PopulationsNASDAQ:TWSTTwist Bioscience Corporation
2024/03/0906:05Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:TWSTTwist Bioscience Corporation
2024/03/0906:05Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:TWSTTwist Bioscience Corporation
2024/03/0906:05Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:TWSTTwist Bioscience Corporation
2024/03/0906:05Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:TWSTTwist Bioscience Corporation
2024/03/0906:05Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:TWSTTwist Bioscience Corporation
2024/03/0705:32Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:TWSTTwist Bioscience Corporation
2024/03/0705:26Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:TWSTTwist Bioscience Corporation
2024/03/0705:20Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:TWSTTwist Bioscience Corporation
2024/03/0705:18Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:TWSTTwist Bioscience Corporation
2024/03/0705:17Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:TWSTTwist Bioscience Corporation
2024/03/0522:00Business WireTwist Bioscience Launches IVDR-compliant Precision Dx Products for Whole Exome SequencingNASDAQ:TWSTTwist Bioscience Corporation
2024/02/2222:00Business WireTwist Bioscience to Present at Upcoming Investor ConferencesNASDAQ:TWSTTwist Bioscience Corporation
2024/02/1307:42Edgar (US Regulatory)Form SC 13G - Statement of acquisition of beneficial ownership by individualsNASDAQ:TWSTTwist Bioscience Corporation
2024/02/1006:10Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:TWSTTwist Bioscience Corporation
2024/02/1006:10Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:TWSTTwist Bioscience Corporation
2024/02/0905:14Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:TWSTTwist Bioscience Corporation
2024/02/0806:05Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:TWSTTwist Bioscience Corporation
2024/02/0722:00Business WireTwist Bioscience Corporation Announces Inducement Grants under NASDAQ Listing Rule 5635(c)(4)NASDAQ:TWSTTwist Bioscience Corporation
2024/02/0706:05Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:TWSTTwist Bioscience Corporation
2024/02/0706:05Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:TWSTTwist Bioscience Corporation
 검색 관련기사 보기:NASDAQ:TWST

최근 히스토리

EU
G199T
G199T
ASX
AZXN
NASDAQ
NVMI
Nova
LSE
0OGI
COIN
AIBBUSD
Ai BubBle
TSXV
VPG
COIN
SJWGBP
NYSE
DWIN.WS
Delwinds Insurance Acqui...
TG
471A
Atyr Pharma
BIT
S28166
Societe Generale Effekten
TSX
BPS.PR.U
Brookfield Property Split
COIN
VCNUSD
FX
EURAUD
Euro vs AUD
BIT
F18283
Vontobel Financial Produ...
BIT
UB93DH
Unicredit Bank
BOV
BUFF39
Xtrackers Msci World Val...
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

대한민국
회사 소개
사업
Popular
앱 받기
App Store
Google Play

도움 및 지원받기: kr-support@advfn.com

ADVFN 서비스 이용은 ADVFN의 이용약관에 동의하는 것입니다 이용약관

© 2024 ADVFN PLC - 모든 권리 보유